• Our Services
    • The Information Commons
    • Shifting the Research Paradigm
    • The Cancer Commons Difference
    • Our Approach
  • About Your Cancer
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • About Us
    • Our Story
    • Facing Advanced Cancer
    • Meet the Team that Cares
    • Distinguished Advisors
    • Our Partners
    • Support Our Services
    • Talk to Us
    • Financial Documents
  • Testimonials
    • All Testimonials
  • Support Us
    • Many Ways to Give
    • What Your Support Makes Possible
  • Our Services
    • The Information Commons
    • Shifting the Research Paradigm
    • The Cancer Commons Difference
    • Our Approach
  • About Your Cancer
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • About Us
    • Our Story
    • Facing Advanced Cancer
    • Meet the Team that Cares
    • Distinguished Advisors
    • Our Partners
    • Support Our Services
    • Talk to Us
    • Financial Documents
  • Testimonials
    • All Testimonials
  • Support Us
    • Many Ways to Give
    • What Your Support Makes Possible
 

Using Protein Analysis to Understand Esophageal Cancer

March 8, 2022
Focus: Esophageal Cancer
Topics: Molecular Testing Options

In order to advance knowledge that leads to better treatments for esophageal diseases, biomarkers of genomic, proteomic, and metabolomic types may be required. One company, Stella Diagnostics, received a Biotech Breakthrough Award in 2021 for its proteomics work in this often-neglected cancer.

.

.

Tags: Molecular Testing, proteomics, Stella Diagnostics

Our Mission: Cancer Commons is a non-profit network of patients, scientists, and physicians united by a shared goal—to optimize each patient’s outcome and maximize collective learning to benefit the next patient.

Don’t miss Cancer Commons Connects
Insights and stories—from and for our community

Working.

Our Services

  • Care Navigation
  • Personalized Action Plans
  • Registering with Cancer Commons
  • Frequently Asked Questions (FAQ)

Perspectives

  • Latest Research
  • Treatment Options
  • Molecular Testing
  • Navigating Treatment
  • Living with Cancer
  • Patient Stories
  • Curious Dr. George
  • The Big Picture

Organization

  • Our Story
  • Our Team
  • Our Core Values
  • Board of Directors
  • Partners
  • Expert Physician Advisors
  • Careers

About Us

  • News and Events
  • Financial Documents
  • Contact Us

Support & Giving

  • Contribute Now
  • Many Ways to Give
  • What Your Support Makes Possible
  • Testimonials


Donate

Cancer Commons
2625 Middlefield Road Suite 104
Palo Alto, CA 94306

650-289-4044

Patient Hotline

877-971-1200

  • Privacy Policy

© 2025 Cancer Commons.